Literature DB >> 34001932

Heme cytotoxicity is the consequence of endoplasmic reticulum stress in atherosclerotic plaque progression.

Dávid Pethő1,2, Zoltán Hendrik3, Annamária Nagy1,2, Lívia Beke3, Andreas Patsalos4,5, László Nagy4,5, Szilárd Póliska6, Gábor Méhes3, Csaba Tóth7, László Potor8, John W Eaton9, Harry S Jacob10, György Balla11, József Balla12, Tamás Gáll1,8.   

Abstract

Hemorrhage and hemolysis with subsequent heme release are implicated in many pathologies. Endothelial cells (ECs) encounter large amount of free heme after hemolysis and are at risk of damage from exogenous heme. Here we show that hemorrhage aggravates endoplasmic reticulum (ER) stress in human carotid artery plaques compared to healthy controls or atheromas without hemorrhage as demonstrated by RNA sequencing and immunohistochemistry. In EC cultures, heme also induces ER stress. In contrast, if cultured ECs are pulsed with heme arginate, cells become resistant to heme-induced ER (HIER) stress that is associated with heme oxygenase-1 (HO-1) and ferritin induction. Knocking down HO-1, HO-2, biliverdin reductase, and ferritin show that HO-1 is the ultimate cytoprotectant in acute HIER stress. Carbon monoxide-releasing molecules (CORMs) but not bilirubin protects cultured ECs from HIER stress via HO-1 induction, at least in part. Knocking down HO-1 aggravates heme-induced cell death that cannot be counterbalanced with any known cell death inhibitors. We conclude that endothelium and perhaps other cell types can be protected from HIER stress by induction of HO-1, and heme-induced cell death occurs via HIER stress that is potentially involved in the pathogenesis of diverse pathologies with hemolysis and hemorrhage including atherosclerosis.

Entities:  

Year:  2021        PMID: 34001932     DOI: 10.1038/s41598-021-89713-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  65 in total

Review 1.  Overcoming the heme paradox: heme toxicity and tolerance in bacterial pathogens.

Authors:  Laura L Anzaldi; Eric P Skaar
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

Review 2.  Adaptations against heme toxicity in blood-feeding arthropods.

Authors:  Aurélio V Graça-Souza; Clarissa Maya-Monteiro; Gabriela O Paiva-Silva; Glória R C Braz; Márcia C Paes; Marcos H F Sorgine; Marcus F Oliveira; Pedro L Oliveira
Journal:  Insect Biochem Mol Biol       Date:  2006-01-19       Impact factor: 4.714

3.  Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases.

Authors:  U Muller-Eberhard; J Javid; H H Liem; A Hanstein; M Hanna
Journal:  Blood       Date:  1968-11       Impact factor: 22.113

Review 4.  Heme: Modulator of Plasma Systems in Hemolytic Diseases.

Authors:  Lubka T Roumenina; Julie Rayes; Sébastien Lacroix-Desmazes; Jordan D Dimitrov
Journal:  Trends Mol Med       Date:  2016-02-12       Impact factor: 11.951

5.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Authors:  Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

Review 6.  Hemopexin: structure, function, and regulation.

Authors:  Emanuela Tolosano; Fiorella Altruda
Journal:  DNA Cell Biol       Date:  2002-04       Impact factor: 3.311

Review 7.  Bilirubin chemistry and metabolism; harmful and protective aspects.

Authors:  Libor Vítek; J Donald Ostrow
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 8.  Toxicity of iron and hydrogen peroxide: the Fenton reaction.

Authors:  C C Winterbourn
Journal:  Toxicol Lett       Date:  1995-12       Impact factor: 4.372

9.  The lipocalin alpha(1)-microglobulin binds heme in different species.

Authors:  Jörgen Larsson; Maria Allhorn; Bo Kerström
Journal:  Arch Biochem Biophys       Date:  2004-12-15       Impact factor: 4.013

Review 10.  Heme as a Target for Therapeutic Interventions.

Authors:  Stephan Immenschuh; Vijith Vijayan; Sabina Janciauskiene; Faikah Gueler
Journal:  Front Pharmacol       Date:  2017-04-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.